NCT04287777 - Safety and Efficacy of Mupirocin Gel in Children With Impetigo | Biotech Hunter

Enrollment

467

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Impetigo

Interventions

DRUG

Mupirocin gel

Topical administration of Mupirocin gel 20 mg/g BID for 7 days

DRUG

Mupirocin ointment

Topical treatment of Mupirocin ointment 20 mg/g TID for 7 days

DRUG

Placebo

Topical administration of Placebo (ointment) TID during 7 days

Trial Locations (20)

21942

H.U. Fuenlabrada, Fuenlabrada

25007

CAP Rambla Ferran, Lleida

28003

CAP Cea Bermúdez, Madrid

28007

Hospital Gregorio MArañón, Madrid

28018

CAP Campo de la Paloma, Madrid

28023

CAP Aravaca, Madrid

28026

CAP La Calesas, Madrid

28224

CAP Pozuelo de Alarcón, Pozuelo de Alarcón

28320

CAP Pinto, Pinto

28500

H.U. Sureste, Arganda

28702

H.U. Infanta Sofía, San Sebastián de los Reyes

28945

CAP Castilla la Nueva, Fuenlabrada

41016

CAP Torreblanca, Seville

41980

CAP La Algaba, Seville

08023

CAP Vallcarca-St. Gervasi, Barcelona

08757

CAP Corbera de Llobregat, Corbera de Llobregat

08902

CAP Amadeu Torner, L'Hospitalet de Llobregat

CAP Mossèn Cinto Verdager, L'Hospitalet de Llobregat

08905

CAP Florida Nord, L'Hospitalet de Llobregat

08840

CAP Maria Bernades, Viladecans

All Listed Sponsors

lead

Reig Jofre Group

INDUSTRY